Fragile X Mental Retardation Syndrome (FMR1)


Dred_IDRD00035
OMIM ID300624
Disease nameFragile X Mental Retardation Syndrome
Alternative namesFragile X Syndrome
Mental Retardation, X-linked, Associated with Marxq28
X-linked Mental Retardation and Macroorchidism
Marker X Syndrome
Martin-bell Syndrome
CategoryGenetic diseases, Rare diseases, Neuronal diseases, Eye diseases, Reproductive diseases, Endocrine diseases, Fetal diseases, Mental diseases
PhenotypeNIH Rare Diseases: Fragile X syndrome is a genetic condition involving changes in part of the X chromosome. This condition causes a range of developmental problems including learning disabilities and cognitive impairment. It is the most common form of inheritedintellectual disability in males and a significant cause of intellectual disability in females. Other signs and symptoms may include symptoms of autism spectrum disorders, seizures, and characteristic physical features. Fragile X syndrome is caused by a change (mutation) in the FMR1 gene and is inherited in an X-linked dominant manner. There is no cure yet and treatment is based on the symptoms present in the person. Early physical and education therapy is recommended.

OMIM: Fragile X syndrome is characterized by moderate to severe mental retardation, macroorchidism, and distinct facial features, including long face, large ears, and prominent jaw. In most cases, the disorder is caused by the unstable expansion of a CGG repeat in the FMR1 gene and abnormal methylation, which results in suppression of FMR1 transcription and decreased protein levels in the brain (Devys et al., 1993).
MiscellaneouseOMIM: incomplete penetrance 50% of females have learning disability or mild mental retardation prevalence approximately 1 in 4,000 males most cases (98%) caused by expanded trinucleotide repeat (cgg)n in the fmr1 gene repeat is unstable if > 52 repeats symptomatic if > 200 repeats some boys with premutations (55 to 200 repeats) may show milder features, including autistic features
PrevalencePrevalence: 1-5/10000 (Worldwide),1-5/10000 (Europe),1-9/100000 (United States),1-9/100000 (France),1-5/10000 (Spain),1-5/10000 (Canada) [source: MalaCards]
InheritanceX-linked dominant
AnticipationYes
EvidenceStrong
Gene symbolFMR1
Alias symbolsPOF, FMRP, POF1, FRAXA
Gene namefragile X mental retardation 1
Gene map locusXq27.3; 147,911,919-147,951,125(+)
Ensembl Gene IDENSG00000102081
Gene expression and Gene OntologyBioGPS
Protein expressionHuman Protein Atlas
Gene sequenceSequence
VariationClinVar,  dbSNP
Gene conservationGene Conservation from UCSC Genome Browser
Gene DescriptionThe protein encoded by this gene binds RNA and is associated with polysomes. The encoded protein may be involved in mRNA trafficking from the nucleus to the cytoplasm. A trinucleotide repeat (CGG) in the 5' UTR is normally found at 6-53 copies, but an expansion to 55-230 repeats is the cause of fragile X syndrome. Expansion of the trinucleotide repeat may also cause one form of premature ovarian failure (POF1). Multiple alternatively spliced transcript variants that encode different protein isoforms and which are located in different cellular locations have been described for this gene. [provided by RefSeq, May 2010]
Repeat unitCGG
Normal repeat copies6-52
Pathogenic repeat copies≥231
GeneFMR1/FMR4
Repeat location5' UTR
Chromosome locuschrX:147912051-147912113 (+)
Repeat conservationRepeat Conservation from UCSC Genome Browser
Toxic causeRNA
Possible toxicityFragile X mental retardation is characterized by moderate to severe mental retardation, macroorchidism, and distinct facial features, including long face, large ears, and prominent jaw. In most cases, the disorder is caused by the unstable expansion of a CGG repeat in the FMR1 gene and abnormal methylation, which results in suppression of FMR1 transcription and decreased protein levels in the brain
Pathway annotationReactome, KEGG
PMID15052536
AuthorsHagerman PJ, Hagerman RJ.
TitleThe fragile-X premutation: a maturing perspective
JournalAm J Hum Genet. 75(2):352
Year2004
PMID24578575
AuthorsColak D, Zaninovic N, Cohen MS, Rosenwaks Z, Yang WY, Gerhardt J, Disney MD, Jaffrey SR
TitlePromoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome
JournalScience. 28;343(6174):1002-5
Year2014


© 2024 Database of repeat expansion diseases.
Data collected by OmicsLab, IGDB, CAS. All rights reserved.